Skip to main content

Table 1 Baseline characteristics of patients included in the study

From: Choroidal measurements in decision making for retinopathy of prematurity: a decision tree analysis

Variable

Label

Need to treat

Treatment type

No

Yes

Sig.

IVB

Laser

Sig.

Sex

Female

14 (70%)

45 (47%)

0.06

7 (58%)

38 (46%)

0.41

Male

6 (30%)

50 (53%)

5 (42%)

45 (54%)

Postmenstrual age

Mean ± SD

42.3 ± 7.8

38.7 ± 3.24

0.15

35.6 ± 5.29

39.25 ± 2.52

0.001

Gestational age

Mean ± SD

31.2 ± 4.5

29.35 ± 1.83

0.29

28 ± 1.28

29.5 ± 1.82

0.008

Birth weight

Mean ± SD

1508 ± 590

1285 ± 337

0.1

1121.67 ± 181

1310 ± 349

0.08

Treatment with O2

Yes

1 (5%)

83 (87%)

0.001

10 (83%)

73 (88%)

0.65

Mechanical ventilation

Yes

1 (5%)

35 (37%)

0.005

8 (67%)

27 (33%)

0.02

Sepsis

Yes

0 (0%)

7 (7%)

0.21

1 (8%)

6 (7%)

0.89

Jaundice

Yes

1 (5%)

38 (40%)

0.003

5 (42%)

33 (40%)

0.90

Blood transfusion

Yes

0 (0%)

36 (38%)

0.001

5 (42%)

31 (37%)

0.77

Anemia

Yes

0 (0%)

18 (19%)

0.03

3 (25%)

15 (18%)

0.56

Gestational diabetes mellitus

Yes

0 (0%)

18 (19%)

0.03

2 (17%)

16 (19%)

0.82

Zone

I

0 (0%)

9 (9%)

0.001

4 (33%)

5 (6%)

0.001

II

10 (50%)

81 (85%)

3 (25%)

78 (94%)

II posterior

0 (0%)

4 (4%)

4 (33%)

0 (0%)

III

5 (25%)

1 (1%)

1 (8%)

0 (0%)

Complete vascularization

5 (25%)

0 (0%)

0 (0%)

0 (0%)

Aggressive posterior ROP

 

0 (0%)

0 (0%)

 

0 (0%)

0 (0%)

 

Stage

0

5 (25%)

0 (0%)

0.001

0 (0%)

0 (0%)

0.02

1

9 (60%)

1 (1%)

1 (10%)

0 (0%)

2

0 (0%)

5 (6%)

0 (0%)

5 (6%)

3

0 (0%)

76 (86%)

9 (90%)

67 (86%)

4

0 (0%)

6 (7%)

0 (0%)

6 (8%)

Plus stage

No plus

17 (100%)

1 (1%)

0.001

1 (10%)

0 (0%)

0.02

Pre-plus

0 (0%)

15 (17%)

0 (0%)

15 (19%)

Plus

0 (0%)

72 (82%)

9 (90%)

63 (81%)

  1. IVB intravitreal bevacizumab